全球血液检测市场规模、份额、趋势和成长分析报告（2026-2034年）

预计血液检测市场将从 2025 年的 1,103 亿美元成长到 2034 年的 2,270.1 亿美元，2026 年至 2034 年的复合年增长率为 8.35%。

全球血液检测市场正经历显着成长，这主要得益于慢性病盛行率的上升和预防医学意识提升。定期血液检测对于诊断糖尿病、心血管疾病和感染疾病等疾病至关重要。人口老化和全球诊断检查室的扩张推动了对先进血液检测解决方案的需求。自动化分析仪和快速诊断试剂盒的技术创新也进一步促进了市场扩张。

关键成长要素包括医疗费用支出增加、对疾病早期检测的需求不断增长以及就地检验服务的扩展。政府推行的促进定期健康检查和改善农村地区诊断服务可近性的政策正在推动市场发展。此外，分子诊断技术和个人化医疗的进步正在拓展血液检测的应用范围。家用检测套组的广泛普及也促进了产业成长。

展望未来，人工智慧（AI）、数位健康平台和检查室自动化技术的整合预计将推动市场呈现强劲成长动能。远端医疗服务的扩展和分散式检查模式的普及将创造新的机会。生物标记发现和精准诊断领域的持续研究将进一步提升市场成长潜力。随着预防医学日益受到重视，血液检测市场将继续在全球医疗诊断领域中占有重要地位。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球血液检测市场：依检测类型划分

• 市场分析、洞察与预测
• 血脂检查
• 摄护腺特异性抗原
• 冠状病毒感染疾病（COVID-19）
• 血液常规检查（CBC）
• 血中尿素氮（BUN）检测
• 血糖测试
• A1c
• 直接低密度脂蛋白
• 皮质醇
• 肌酸酐
• 其他测试

第五章 全球血液检测市场：依最终用户划分

• 市场分析、洞察与预测
• 医院
• 诊所
• 诊断中心
• 研究所
• 其他（血库）

第六章 全球血液检测市场：依检测方法划分

• 市场分析、洞察与预测
• 手动的
• 自动化

第七章 全球血液检测市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Abbott Diagnostics
  • Bio-Rad Laboratories Inc
  • Roche Diagnostics
  • Quest Diagnostics
  • Danaher Corporation
  • Becton Dickinson & Company
  • Biomerica Inc
  • BioMAfA（C）Rieux SA
  • Siemens Healthcare
  • Trinity Biotech PLC

The Blood Testing Market size is expected to reach USD 227.01 Billion in 2034 from USD 110.30 Billion (2025) growing at a CAGR of 8.35% during 2026-2034.

The Global Blood Testing Market is experiencing substantial growth driven by increasing prevalence of chronic diseases and rising awareness about preventive healthcare. Routine blood tests are essential for diagnosing conditions such as diabetes, cardiovascular disorders, and infections. The growing geriatric population and expansion of diagnostic laboratories worldwide are fueling demand for advanced blood testing solutions. Technological innovations in automated analyzers and rapid diagnostic kits are further supporting market expansion.

Major growth drivers include increasing healthcare expenditure, rising demand for early disease detection, and expansion of point-of-care testing services. Government initiatives promoting routine health screenings and improved access to diagnostic services in rural regions are strengthening the market landscape. Moreover, advancements in molecular diagnostics and personalized medicine are expanding the application scope of blood testing. The adoption of home-based testing kits is also contributing to industry growth.

Looking forward, the market is expected to witness strong momentum due to integration of artificial intelligence, digital health platforms, and automation in laboratories. Expansion of telehealth services and decentralized testing models will create new opportunities. Continuous research in biomarker discovery and precision diagnostics will further enhance growth potential. With increasing focus on preventive healthcare, the blood testing market will remain a cornerstone of global medical diagnostics.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Test Type

• Lipid Panel Testing
• Prostate-Specific Antigen
• Covid-19
• Complete Blood Count (CBC)
• Bun Testing (Blood Urea Nitrogen)
• Glucose Testing
• A1c
• Direct Ldl
• Cortisol
• Creatinine
• Others Tests

By End User

• Hospitals
• Clinics
• Diagnostic Centre
• Research Laboratories
• Others (Blood Banks)

By Method

• Manual
• Automated

COMPANIES PROFILED

• Abbott Diagnostics, BioRad Laboratories Inc, Roche Diagnostics, Quest Diagnostics, Danaher Corporation, Becton Dickinson Company, Biomerica Inc, bioMrieux SA, Siemens Healthcare, Trinity Biotech PLC
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BLOOD TESTING MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Test Type
• 4.2. Lipid Panel Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Prostate-Specific Antigen Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Covid-19 Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Complete Blood Count (CBC) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Bun Testing (Blood Urea Nitrogen) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Glucose Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. A1c Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. Direct Ldl Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.10. Cortisol Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.11. Creatinine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.12. Others Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BLOOD TESTING MARKET: BY END USER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End User
• 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Diagnostic Centre Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Research Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others (Blood Banks) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BLOOD TESTING MARKET: BY METHOD 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Method
• 6.2. Manual Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Automated Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BLOOD TESTING MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Test Type
  • 7.2.2 By End User
  • 7.2.3 By Method
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Test Type
  • 7.3.2 By End User
  • 7.3.3 By Method
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Test Type
  • 7.4.2 By End User
  • 7.4.3 By Method
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Test Type
  • 7.5.2 By End User
  • 7.5.3 By Method
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Test Type
  • 7.6.2 By End User
  • 7.6.3 By Method
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BLOOD TESTING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Abbott Diagnostics
  • 9.2.2 Bio-Rad Laboratories Inc
  • 9.2.3 Roche Diagnostics
  • 9.2.4 Quest Diagnostics
  • 9.2.5 Danaher Corporation
  • 9.2.6 Becton Dickinson & Company
  • 9.2.7 Biomerica Inc
  • 9.2.8 BioMAfA(C)Rieux S.A
  • 9.2.9 Siemens Healthcare
  • 9.2.10 Trinity Biotech PLC